Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.37 |
| ▸ | PRMT5 | O14744 | 2/20 | 0.35 |
| ▸ | WDR77 | Q9BQA1 | 2/20 | 0.35 |
| ▸ | MCHR1 | Q99705 | 8/20 | 0.34 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.34 |
| ▸ | GRM5 | P41594 | 1/20 | 0.33 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.33 |
| ▸ | AOC3 | Q16853 | 3/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29987302 | 1.00 | HRH3 (0.37) | HRH3PRMT5WDR77MCHR1PDE10A | |
| SCHEMBL24667421 | 0.93 | PRMT5 (0.36) | HRH3PRMT5WDR77MCHR1GRM5 | |
| SCHEMBL29986698 | 0.93 | PRMT5 (0.36) | HRH3PRMT5WDR77MCHR1GRM5 | |
| SCHEMBL29986770 | 0.90 | PRMT5 (0.34) | HRH3PRMT5WDR77MCHR1PDE10A | |
| SCHEMBL29987742 | 0.89 | HRH3 (0.33) | HRH3MCHR1PDE10AGRM5SLC6A3 | |
| SCHEMBL24667443 | 0.89 | HRH3 (0.33) | HRH3MCHR1PDE10AGRM5SLC6A3 | |
| SCHEMBL24667346 | 0.89 | GRM5 (0.42) | HRH3PRMT5WDR77MCHR1PDE10A | |
| SCHEMBL29987375 | 0.89 | GRM5 (0.42) | HRH3PRMT5WDR77MCHR1PDE10A | |
| SCHEMBL24667586 | 0.88 | PRMT5 (0.45) | PRMT5WDR77MCHR1GRM5 | |
| SCHEMBL29986992 | 0.88 | PRMT5 (0.45) | PRMT5WDR77MCHR1GRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220339302-A1 | ISOINDOLINONE COMPOUNDS AND IMAGING AGENTS FOR IMAGING HUNTINGTIN PROTEIN | CHDI FOUNDATION, INC. | 2022-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220339302-A1 | ISOINDOLINONE COMPOUNDS AND IMAGING AGENTS FOR IMAGING HUNTINGTIN PROTEIN | HTT, HYPK, HSPBP1 | HRH3 3604/4885PRMT5 3280/4885WDR77 2074/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.